Like most websites, we use cookies and other similar technologies for a number of reasons, such as keeping our website reliable and secure, personalizing content, providing social media features and to better understand how our site is used. By using our site, you are agreeing to our use of these tools. Learn More

Your Location is set to:

PREDICT-RT

Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating Deintensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation NCT04513717

Objective

This clinical trial compares de-intensification therapy vs. intensification therapy in high risk prostate cancer. Objective is to evaluate the effectiveness of de-intensification therapy in high risk prostate cancer.

Principal Investigator(s)
Jeffrey Martin, MD

Clinical Trial Categories

  • Treatment
  • Prostate Cancer
Contact
Christine Neely-Jones, RN at 508-862-7298
or cneelyjones@capecodhealth.org
How to Participate

Contact your oncologist, oncology nurse or the Oncology Research Program Manager.